-The Hindu Business Line   Opening bank accounts in rural areas is all very well, but biometric frauds are a serious possibility The ambitious Pradhan Mantri Jan Dhan Yojana (PMJDY) aims at bringing millions of rural Indians within the financial mainstream by opening bank accounts. In 2006, the Reserve of India, recognising that a majority of rural Indians had little or no access to banking services, allowed banks to use third-party, non-bank agents...

-The Hindu Business Line   Anonymity can protect unpopular individuals from retaliation - and their ideas from suppression - at the hand of an intolerant society The Supreme Court of India has, thankfully, decided to reconsider an earlier order calling for revealing the identity of the whistle-blower while hearing a petition alleging gross misconduct against the Director of the country's foremost police agency, the Central Bureau of Investigation (CBI). On September 15, a...

-Tehelka The Centre must empower forest-dwellers and strengthen legislation instead of bypassing the Forest Rights Act and playing into increased conflict What did not raise much chatter last week was a hint that the ‘development' juggernaut was considering scrapping the Forest Rights Act, using one of many backdoor methods available to bypass legislation. It will force the country back to intense mineral-based conflict and also the never-ending struggle for land, which fill over-crowded...

-The Times of India NEW DELHI: Instead of easing the flow of traffic, as many as 16 flyovers in the city have become major sites of accidents because of faulty design, traffic police said. Nearly 20% of fatal accidents in Delhi occur on these stretches. Police said most of the accidents take place at the mouths of the flyovers because proper Merging (and splitting) distance has not been provided for traffic. These...

-The Business Standard A ray of hope for Indian generic drug makers Gilead Sciences, the California-headquartered biotechnology company, has authorised seven India-based drug makers - Cipla, Ranbaxy, Mylan, Strides Arcolab, Hetero, Cadila Healthcare and Sequent Scientific - to manufacture and sell the generic versions of its hepatitis C medicine, Sovaldi, in 91 developing countries. Earlier in the week, Lupin, the fourth largest Indian drug maker, announced that it will develop and supply...